No Data
Concept mining | Simgeglutide weight loss drug officially launched in China, multiple e-commerce platforms have gone online
The market has broad prospects
Express News | hybio pharmaceutical: Former director Yuan Jiancheng was finally sentenced for embezzlement and sentenced to three years and six months in prison.
Hybio Pharmaceutical (300199.SZ): on October 30th, large-scale shipments of Lirarutide injections were delivered, with a total value of 0.103 billion yuan.
Gelonghui, November 4th | Hybio Pharmaceutical (300199.SZ) stated on the investor interaction platform that on October 30th, the company's Liraglutide injection saw a large-scale shipment, with a total value of 0.103 billion yuan, as per the commercial bulk order announced by the company on November 3, 2023. In the future, the company will maintain a long-term exclusive partnership with Hikma according to the agreement, continue to advance subsequent order shipments based on the demand in the USA sales market, and receive double-digit sales profit sharing. Apart from this order, the company will gradually issue subsequent orders based on project progress. Please stay tuned for future order fulfillment.
hybio pharmaceutical (300199): The performance in Q3 2024 meets expectations, hybio pharmaceutical continues to lead the peptide industry.
Event: On October 29, 2024, hybio pharmaceutical released the third quarter report of 2024, achieving revenue of 0.375 billion yuan in 2024Q1-3 (-6.56% YoY), net income attributable to the parent company -0.3 billion.
Hanyu Pharmaceutical: Report for the third quarter of 2024
Express News | Hybio Pharmaceutical: net income in the third quarter was a loss of 24.4468 million yuan
No Data
No Data